These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 25295493)

  • 61. Letter by Garcia-Moll Regarding Article, "Glycemic Control Status After Percutaneous Coronary Intervention and Long-Term Clinical Outcomes in Patients With Type 2 Diabetes Mellitus".
    Garcia-Moll X
    Circ Cardiovasc Interv; 2017 Aug; 10(8):. PubMed ID: 28760778
    [No Abstract]   [Full Text] [Related]  

  • 62. Abluminus DES: a step forward in the fight against diabetes?
    Asmarats L; Shoeib O; Cortese B
    Minerva Cardiol Angiol; 2021 Oct; 69(5):522-524. PubMed ID: 33427428
    [No Abstract]   [Full Text] [Related]  

  • 63. Response to: "The Stent's Gatekeeper: Inflow Disease".
    Morris R; Black S; Saha P
    Eur J Vasc Endovasc Surg; 2022 Dec; 64(6):739. PubMed ID: 35872343
    [No Abstract]   [Full Text] [Related]  

  • 64. Polymer Free Amphilimus Drug Eluting Stent for Infrapopliteal Arterial Disease in Patients with Critical Limb Ischemia: A New Device in the Armamentarium.
    Tigkiropoulos K; Abatzis-Papadopoulos M; Sidiropoulou K; Stavridis K; Karamanos D; Lazaridis I; Saratzis N
    Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676663
    [No Abstract]   [Full Text] [Related]  

  • 65. Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: the SUGAR trial.
    Romaguera R; Salinas P; Gomez-Lara J; Brugaletta S; Gómez-Menchero A; Romero MA; García-Blas S; Ocaranza R; Bordes P; Kockar MJ; Salvatella N; Jiménez-Díaz VA; Alameda M; Trillo R; Lee DH; Martín P; López-Benito M; Freites A; Pascual-Tejerina V; Hernández-Hernández F; Blanco BGD; Mohandes M; Bosa F; Pinar E; Roura G; Comin-Colet J; Fernández-Ortiz A; Macaya C; Rossello X; Sabate M; Pocock SJ; Gómez-Hospital JA;
    Eur Heart J; 2022 Mar; 43(13):1320-1330. PubMed ID: 34735004
    [TBL] [Abstract][Full Text] [Related]  

  • 66. One-year clinical outcome of amphilimus polymer-free drug-eluting stent in diabetes mellitus patients: Insight from the ASTUTE registry (AmphilimuS iTalian mUlticenTre rEgistry).
    Colombo A; Godino C; Donahue M; Testa L; Chiarito M; Pavon AG; Colantonio R; Cappelletti A; Monello A; Magni V; Milazzo D; Parisi R; Nicolino A; Moshiri S; Fattori R; Aprigliano G; Palloshi A; Caramanno G; Montorfano M; Bedogni F; Margonato A; Briguori C
    Int J Cardiol; 2016 Jul; 214():113-20. PubMed ID: 27060269
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Everolimus-eluting Xience v/Promus versus zotarolimus-eluting resolute stents in patients with diabetes mellitus.
    Park KW; Lee JM; Kang SH; Ahn HS; Kang HJ; Koo BK; Rhew JY; Hwang SH; Lee SY; Kang TS; Kwak CH; Hong BK; Yu CW; Seong IW; Ahn T; Lee HC; Lim SW; Kim HS
    JACC Cardiovasc Interv; 2014 May; 7(5):471-81. PubMed ID: 24852802
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Polymer-free amphilimus-eluting stents in patients with diabetes mellitus.
    Romaguera R; Gómez-Lara J; Jacobi F; Gomez-Hospital JA; Cequier A
    Minerva Cardioangiol; 2014 Oct; 62(5):421-6. PubMed ID: 25295493
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Advances with polymer-free amphilimus-eluting stents.
    CARRIé D
    Minerva Cardioangiol; 2016 Jun; 64(3):339-53. PubMed ID: 26934663
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The Cre8 amphilimus-eluting stent for the treatment of coronary artery disease: safety and efficacy profile.
    Pivato CA; Leone PP; Petriello G; Sanz-Sanchez J; Chiarito M; Stefanini GG
    Expert Rev Med Devices; 2020 Apr; 17(4):267-275. PubMed ID: 32151183
    [No Abstract]   [Full Text] [Related]  

  • 71. Meta-analysis comparing efficacy and safety of first generation drug-eluting stents to bare-metal stents in patients with diabetes mellitus undergoing primary percutaneous coronary intervention.
    De Luca G; Dirksen MT; Spaulding C; Kelbæk H; Schalij M; Thuesen L; van der Hoeven B; Vink MA; Kaiser C; Musto C; Chechi T; Spaziani G; Diaz de la Llera LS; Pasceri V; Di Lorenzo E; Violini R; Suryapranata H; Stone GW;
    Am J Cardiol; 2013 May; 111(9):1295-304. PubMed ID: 23490029
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
    Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
    Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comparison of 3 biodegradable polymer and durable polymer-based drug-eluting stents in all-comers (BIO-RESORT): rationale and study design of the randomized TWENTE III multicenter trial.
    Lam MK; Sen H; Tandjung K; van Houwelingen KG; de Vries AG; Danse PW; Schotborgh CE; Scholte M; Löwik MM; Linssen GC; Ijzerman MJ; van der Palen J; Doggen CJ; von Birgelen C
    Am Heart J; 2014 Apr; 167(4):445-51. PubMed ID: 24655691
    [TBL] [Abstract][Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.